Stocks · Healthcare · Biotechnology
Tango Therapeutics, Inc. TNGX
$23.08 -0.69% Close, Oct 5, 2026 · NASDAQ · Market cap $3.78B
Strong growth
Next earnings report: Nov 3, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $53.8M, up 121.5% from a year earlier, accelerating from 39.0% a quarter earlier.
- Operating margin widened to -253.4% from -647.3% a year earlier.
- The diluted share count rose 35.6% in a year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 9%
- Revenue growth, 3-year CAGRTop 18%
- Revenue growth accelerationTop 4%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 44%
- Gross marginTop 9%
- Operating marginBottom 22%
- Accruals (lower is better)Bottom 14%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 40%
- Free-cash-flow yieldTop 48%
- EBITDA / enterprise valueTop 47%
- Sales / enterprise valueBottom 11%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 7%
- 6-month returnTop 45%
- 1-year return vs S&P 500Top 5%
- Distance from 52-week highBottom 48%
- Trend checklist (0–4)Top 43%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 4%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyTop 23%
- Upside to consensus price targetTop 38%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 35%
- Maximum drawdown, 3 yearsBottom 12%
- Beta vs S&P 500 (lower is better)Bottom 46%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 39.0% | 121.5% | ↑ |
| Gross margin | 97.4% | 98.2% | ↑ |
| Operating margin | -647.3% | -253.4% | ↑ |
| FCF margin | -613.9% | -268.1% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 121.5% | 39.0% | ↑ | Top 9% |
| Gross margin | 98.2% | 97.4% | ↑ | Top 9% |
| Operating margin | -253.4% | -647.3% | ↑ | Bottom 22% |
| Net margin | -229.9% | -599.1% | ↑ | — |
| Free-cash-flow margin | -268.1% | -613.9% | ↑ | — |
| Return on invested capital | -12.9% | — | Top 44% | |
| Revenue growth, 3-year CAGR | 35.9% | — | Top 18% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 1.9%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 74.9%
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -25.77%
- Shareholder yield
- -25.77%
- Share count change, 1 year
- +35.6%
- Share count change, 3-year CAGR
- +19.3%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 11, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- +100.0%
- Average 2-day reaction, last 8
- +2.9%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $45.91
- Target vs current price
- +98.9%
- Analysts with a rating
- 13
- Share rating Buy or Strong Buy
- 92%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 10, 2026 | -16.6% | +2.2% | -5.4% | -16.8% | — |
| May 13, 2026 | -2.0% | +8.6% | -13.6% | +22.0% | +15.2% |
| Mar 5, 2026 | +6.5% | +36.3% | +37.6% | +71.8% | +78.0% |
| Nov 4, 2025 | +1200.0% | +0.0% | -1.0% | +25.8% | +44.9% |
| Aug 5, 2025 | +0.0% | +4.9% | -2.7% | +1.1% | +18.2% |
| May 12, 2025 | -5.9% | +14.9% | +31.6% | +264.9% | +470.2% |
| Feb 27, 2025 | -9.4% | -6.4% | -10.3% | -33.9% | -19.7% |
| Nov 6, 2024 | +20.6% | -37.5% | -35.3% | -32.0% | -41.3% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.37 | -$0.32 | -16.6% | — |
| May 13, 2026 | -$0.32 | -$0.31 | -2.0% | — |
| Mar 5, 2026 | -$0.29 | -$0.31 | +6.5% | — |
| Nov 4, 2025 | $0.13 | $0.01 | +1200.0% | $53.8M |
| Aug 5, 2025 | -$0.35 | -$0.35 | +0.0% | $3.2M |
| May 12, 2025 | -$0.36 | -$0.34 | -5.9% | $5.4M |
| Feb 27, 2025 | -$0.35 | -$0.32 | -9.4% | $4.1M |
| Nov 6, 2024 | -$0.27 | -$0.34 | +20.6% | $11.6M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 64.49× | — | — | Bottom 11% |
| Free-cash-flow yield | -3.81% | — | — | Top 48% |
| Earnings yield | -3.68% | — | — | Top 40% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 334
- 50-day average slope (20 days)
- -8.3%
- 200-day average slope (20 days)
- +7.3%
- Distance from 50-day average
- -7.2%
- Distance from 200-day average
- +9.8%
- RSI (14)
- 44.0
- Relative volume
- 0.59×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 64.4%
- Volatility vs own 5-year history
- 20th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.18
- Correlation with S&P 500
- 0.15
- Current drawdown from 1-year high
- -29.8%
- Maximum drawdown, 3 years
- -91.5%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Sep 17, 2021 | May 8, 2025 | -93.6% | 913 days | 212 days (Mar 13, 2026) |
| Jun 15, 2026 | Sep 18, 2026 | -33.9% | 66 days | Not yet recovered |
| Apr 21, 2026 | May 27, 2026 | -29.2% | 25 days | 8 days (Jun 8, 2026) |
| Feb 22, 2021 | Aug 12, 2021 | -27.0% | 120 days | 17 days (Sep 7, 2021) |
| Jan 7, 2021 | Feb 5, 2021 | -13.4% | 20 days | 10 days (Feb 22, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $3.78B
- EPS, diluted (TTM)
- -$0.85
- Revenue (TTM)
- $53.8M
- 52-week range
- $6.69 – $34.39
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $37.0M | $24.9M | $36.5M | $42.1M | $62.4M |
| Gross profit | $37.0M | $24.9M | $36.5M | $42.1M | $60.1M |
| Operating income | -$58.2M | -$111.1M | -$114.2M | -$145.6M | -$111.3M |
| Net income | -$58.2M | -$108.2M | -$101.7M | -$130.3M | -$101.6M |
| EPS (diluted) | -$0.94 | -$1.23 | -$1.08 | -$1.19 | -$0.87 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.6M | $4.1M | $5.4M | $3.2M | $53.8M | $0 | $0 | $0 |
| Net income | -$29.2M | -$37.7M | -$39.9M | -$38.9M | $15.9M | -$38.7M | -$45.5M | -$55.3M |
| EPS (diluted) | -$0.27 | -$0.34 | -$0.36 | -$0.35 | $0.14 | -$0.30 | -$0.32 | -$0.37 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$59.5M | -$109.1M | -$118.0M | -$131.5M | -$138.9M |
| Capital expenditure | -$1.8M | -$7.7M | -$1.5M | -$754,000 | -$1.0M |
| Free cash flow | -$61.4M | -$116.8M | -$119.5M | -$132.3M | -$139.9M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $0 | $0 | $80.0M | $41.7M | $222.5M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $1.01B
- Total assets
- $1.07B
- Total liabilities
- $49.3M
- Total debt
- $32.0M
- Net debt
- -$313.6M
- Shareholders’ equity
- $1.02B
As of Jun 30, 2026 (filed Aug 11, 2026).
Short interest
- Shares sold short
- 41,872,812
- Days to cover
- 18.76
- Change vs previous report
- -1.8%
FINRA short interest, settlement date Sep 15, 2026.